Aptiv Q3 revenue up 2% but adjusted EBITDA margin slips to 17.7%, signaling execution challenges post-spin

What happened

Aptiv reported third-quarter revenue of $3.2 billion, up 2% year over year, but adjusted EBITDA fell 5.2% to $567 million with margin contracting 140 basis points to 17.7% from 19.1% a year earlier. This result is below the base case outlined in the prior DeepValue report, which projected New Aptiv to grow revenue 4–5% annually and achieve EBITDA margins around 19–20%, indicating slower growth and margin erosion. The figures likely reflect the standalone performance of New Aptiv following the completed EDS spin-off, as the revenue base aligns with the pro forma estimates of over $12 billion annually. The margin decline may stem from tariff pressures, pricing headwinds from OEMs, or adverse mix shifts, all of which were identified as risks in the report. While a single quarter does not invalidate the long-term structural thesis, it raises concerns about the achievability of the 2028 targets of approximately 21% EBITDA margin and 4–7% revenue CAGR.

Implication

The reported EBITDA margin of 17.7% is below the base-case assumption, implying potential downside to the $90 implied value and increasing the probability of the bear-case scenario near $65. If margin weakness persists for two consecutive quarters, it could trigger a reassessment of the investment case and justify a lower valuation multiple. Investors should closely monitor whether management can offset tariff and cost pressures through pricing actions and cost reductions, as the ability to expand margins is central to the re-rating thesis. The 2% revenue growth, while positive, is below the 4–7% CAGR needed to support the current EV/EBITDA multiple of around 6.9x; without acceleration, the stock may face multiple compression. We recommend a cautious hold rather than aggressive accumulation until there is clearer evidence of margin recovery, growth reacceleration, and realization of spin-related benefits.

Thesis delta

The latest quarterly data shows margin contraction and slower growth than the base case, which modestly reduces our conviction in the near-term execution of New Aptiv's targets. However, the core structural story remains intact: the spin-off is complete, and the company retains a strong backlog and non-auto diversification. We are lowering the probability of the base case and slightly increasing the bear-case probability, but maintain a cautious buy stance pending further evidence.